Midcareer Development in Nonpharmacologic Analgesia

非药物镇痛的职业中期发展

基本信息

项目摘要

Alternative medical methods enjoy broad acceptance by the public, but are rarely integrated into conventional medical practice. In the largest prospective randomized study of its kind, published by the Lancet, the candidate showed that non-pharmacologic analgesia in the form of self- hypnotic relaxation during invasive medical procedures significantly reduces patients' pain anxiety, drug use, number of complications, hemodynamic instability, and procedure time. This results in substantial resource savings. The immediate goal of the candidate is to expand and validate this concept of integrated alternative/conventional health care delivery across disciplines. The long-term goal is the successful transition from scientific investigation to general implementation of acute non-pharmacologic analgesia in clinical settings. The candidate is uniquely situated to achieve the state goals: A strong foundation in laboratory and clinical research as well as her position as Director of International Radiology provides her the necessary credibility to promote and implement mind body intervention during invasive medical procedures. Her acceptance by both conventional medical and mind-body oriented professional societies permit integration of her methods into both communities. The candidate's RO1 and DOD funding focuses on assessment on non-pharmacologic analgesia during invasive vascular procedures and during large core breast biopsy. Under the proposed mid-career award, she will (1) acquire authoritative expertise in the introduction and quality assessment of non- pharmacologic analgesia techniques in conventional clinical settings (2) assume a key role in the newly established Harvard-wide Division for Research and Education and Complementary and Integrative Medical Therapies, and (3) mentor the next generation of researchers and practitioners in this field. Towards these aims the candidate will acquire additional research skills in educational technology, quality assessment, and web-based dissemination; acquire expertise in additional complementary and alternative therapies; and will make available to other researchers data banks, ideas, experience and patients in fully monitored clinical environment. She will assume primary mentoring responsibility for a total of 15 beginning clinical researchers. Upon completion, the candidate will have established herself as an authority in the introduction and quality assessment of combined alternative/conventional medical practices. The mentoring of beginning clinical researchers will have contributed towards fostering a self- sustaining mode of integrated practice in the future.
替代医疗方法被公众广泛接受,但很少被纳入传统医疗实践。在《柳叶刀》上发表的这类最大规模的前瞻性随机研究中,候选研究表明,在侵入性医疗程序中,以自我催眠放松的形式进行的非药物止痛显著降低了患者的疼痛焦虑、药物使用、并发症数量、血流动力学不稳定性和手术时间。这大大节省了资源。候选人的直接目标是扩展和验证跨学科综合替代/传统医疗保健提供的这一概念。长期目标是成功地从科学研究过渡到在临床环境中全面实施急性非药物止痛。候选人在实现国家目标方面具有得天独厚的优势:在实验室和临床研究方面的雄厚基础,以及她作为国际放射学主任的职位,为她在侵入性医疗程序中促进和实施心身干预提供了必要的可信度。她被传统医学和面向身心的专业协会所接受,这使得她的方法能够融入这两个社区。候选人的RO1和DOD资金侧重于评估侵入性血管手术和大型核心乳腺活检期间的非药物止痛。根据拟议的职业中期奖,她将(1)在传统临床环境下非药物止痛技术的介绍和质量评估方面获得权威专业知识(2)在新成立的哈佛大学范围内的研究和教育部门以及补充和综合医学疗法部门担任关键角色,以及(3)指导该领域的下一代研究人员和从业者。为了达到这些目标,候选人将在教育技术、质量评估和基于网络的传播方面获得更多的研究技能;在其他补充和替代疗法方面获得专业知识;并将向其他研究人员提供充分监测临床环境中的数据库、想法、经验和患者。她将承担总共15名初级临床研究人员的主要指导责任。完成后,候选人将确立自己在引入和评估替代/常规综合医疗实践方面的权威。对初级临床研究人员的指导将有助于在未来培养一种自我维持的综合实践模式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELVIRA Valentina LANG-ANDERSON其他文献

ELVIRA Valentina LANG-ANDERSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELVIRA Valentina LANG-ANDERSON', 18)}}的其他基金

Nonpharmacologic reduction of periprocedural pain, anxiety, and prescription drug use
非药物减少围手术期疼痛、焦虑和处方药使用
  • 批准号:
    9345484
  • 财政年份:
    2017
  • 资助金额:
    $ 13.15万
  • 项目类别:
Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging
MR 成像中改善幽闭恐惧症和破坏性患者运动
  • 批准号:
    8199300
  • 财政年份:
    2011
  • 资助金额:
    $ 13.15万
  • 项目类别:
Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging
MR 成像中改善幽闭恐惧症和破坏性患者运动
  • 批准号:
    8777608
  • 财政年份:
    2011
  • 资助金额:
    $ 13.15万
  • 项目类别:
Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging
MR 成像中改善幽闭恐惧症和破坏性患者运动
  • 批准号:
    8309100
  • 财政年份:
    2011
  • 资助金额:
    $ 13.15万
  • 项目类别:
Midcareer Development in Nonpharmacologic Analgesia
非药物镇痛的职业中期发展
  • 批准号:
    6881263
  • 财政年份:
    2002
  • 资助金额:
    $ 13.15万
  • 项目类别:
Midcareer Development in Nonpharmacologic Analgesia
非药物镇痛的职业中期发展
  • 批准号:
    6711790
  • 财政年份:
    2002
  • 资助金额:
    $ 13.15万
  • 项目类别:
Midcareer Development in Nonpharmacologic Analgesia
非药物镇痛的职业中期发展
  • 批准号:
    7034621
  • 财政年份:
    2002
  • 资助金额:
    $ 13.15万
  • 项目类别:
Midcareer Development in Nonpharmacologic Analgesia
非药物镇痛的职业中期发展
  • 批准号:
    6622948
  • 财政年份:
    2002
  • 资助金额:
    $ 13.15万
  • 项目类别:
INFERIOR VENA CAVA FILTRATION WITH A REMOVABLE DEVICE
使用可拆卸装置进行下腔静脉过滤
  • 批准号:
    2716934
  • 财政年份:
    1999
  • 资助金额:
    $ 13.15万
  • 项目类别:
AUTOMATED GAS ENHANCED VASCULAR IMAGING
自动气体增强血管成像
  • 批准号:
    6020400
  • 财政年份:
    1998
  • 资助金额:
    $ 13.15万
  • 项目类别:

相似海外基金

Unravelling the neural basis of breathing, respiratory depression, and analgesia by opioid drugs.
揭示阿片类药物呼吸、呼吸抑制和镇痛的神经基础。
  • 批准号:
    479039
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
    Operating Grants
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
  • 批准号:
    10608439
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Evaluation of the Role of Macrophage Migratory Inhibitory Factor (MIF) in mediating Stem Cell Analgesia in a Model of Orofacial Pain
评估巨噬细胞迁移抑制因子(MIF)在口面部疼痛模型中介导干细胞镇痛的作用
  • 批准号:
    10585412
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Dissociating respiratory depression and analgesia via a data-driven model of interacting respiratory and pain networks
通过呼吸和疼痛网络相互作用的数据驱动模型分离呼吸抑制和镇痛
  • 批准号:
    10644300
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Elucidating causal mechanisms of ethanol-induced analgesia in BXD recombinant inbred mouse lines
阐明 BXD 重组近交系小鼠乙醇诱导镇痛的因果机制
  • 批准号:
    10825737
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Study: A Pilot Randomized Controlled Trial
裸盖菇素用于增强慢性神经病性疼痛 (PEACE-PAIN) 镇痛效果的研究:一项随机对照试验
  • 批准号:
    479442
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
    Operating Grants
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
  • 批准号:
    10759550
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Maintaining opioid analgesia and preventing addiction with hypocretin antagonism
通过下丘脑分泌素拮抗作用维持阿片类药物镇痛并预防成瘾
  • 批准号:
    10713175
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Disease Modifying Analgesia with CA8 Gene Therapy
CA8 基因治疗的疾病修饰镇痛
  • 批准号:
    10710264
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
Circuit mechanisms for opioid analgesia and addiction in prefrontal cortex
前额皮质阿片类镇痛和成瘾的回路机制
  • 批准号:
    10607118
  • 财政年份:
    2023
  • 资助金额:
    $ 13.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了